Invesco
TWST icon

Invesco’s Twist Bioscience TWST Stock Holding History

Invesco’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198M Sell
1,928,229
-243,669
-11% -$15.9M 0.02% 714
2026
Q1 		$103M Buy
2,171,898
+881,627
+68% +$39.5M 0.01% 832
2025
Q4 		$40.9M Sell
1,290,271
-504,872
-28% -$15.8M ﹤0.01% 1164
2025
Q3 		$50.5M Sell
1,795,143
-552,786
-24% -$16.7M 0.01% 1086
2025
Q2 		$86.4M Sell
2,347,929
-1,036,300
-31% -$35.8M 0.01% 858
2025
Q1 		$133M Sell
3,384,229
-200,205
-6% -$9.02M 0.03% 723
2024
Q4 		$167M Sell
3,584,434
-57,996
-2% -$2.62M 0.03% 684
2024
Q3 		$165M Buy
3,642,430
+220,756
+6% +$10.5M 0.03% 669
2024
Q2 		$169M Buy
3,421,674
+965,700
+39% +$39.4M 0.04% 624
2024
Q1 		$84.3M Buy
2,455,974
+760,663
+45% +$27.5M 0.02% 837
2023
Q4 		$62.5M Buy
1,695,311
+864,305
+104% +$20M 0.01% 915
2023
Q3 		$16.8M Buy
831,006
+778,944
+1,496% +$17.1M ﹤0.01% 1433
2023
Q2 		$1.07M Sell
52,062
-3,582
-6% -$53.7K ﹤0.01% 2860
2023
Q1 		$839K Buy
55,644
+25,050
+82% +$553K ﹤0.01% 2983
2022
Q4 		$728K Sell
30,594
-117,446
-79% -$3.41M ﹤0.01% 3090
2022
Q3 		$5.22M Buy
148,040
+32,658
+28% +$1.39M ﹤0.01% 2209
2022
Q2 		$4.04M Sell
115,382
-1,191,576
-91% -$42.2M ﹤0.01% 2400
2022
Q1 		$64.5M Sell
1,306,958
-444,846
-25% -$24.7M 0.02% 917
2021
Q4 		$136M Sell
1,751,804
-17,433
-1% -$1.79M 0.03% 679
2021
Q3 		$189M Sell
1,769,237
-155,910
-8% -$17.9M 0.05% 530
2021
Q2 		$257M Sell
1,925,147
-76,654
-4% -$8.91M 0.06% 397
2021
Q1 		$248M Sell
2,001,801
-287,700
-13% -$43.7M 0.07% 379
2020
Q4 		$323M Buy
2,289,501
+352,029
+18% +$39.1M 0.09% 256
2020
Q3 		$147M Sell
1,937,472
-35,492
-2% -$2.21M 0.05% 483
2020
Q2 		$89.4M Buy
1,972,964
+1,507,870
+324% +$54.1M 0.03% 639
2020
Q1 		$14.2M Buy
+465,094
New +$12.5M 0.01% 1362
2019
Q4 		– Sell
-30,951
Closed -$739K – 3703
2019
Q3 		$739K Sell
30,951
-47,086
-60% -$1.37M ﹤0.01% 3126
2019
Q2 		$2.26M Buy
+78,037
New +$2.06M ﹤0.01% 2646

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Invesco's TWST Position: Q2 2026 in Review

Invesco reduced its Twist Bioscience (TWST) stake by 11% in Q2 2026, selling an estimated $15.9M and leaving 1,928,229 shares worth $198M. The position accounts for 0.02% of the portfolio, ranked #714.

Invesco first reported a position in TWST in Q2 2019 and has held it in 28 quarters since. The position peaked at $323M in Q4 2020. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Invesco held 1,928,229 shares of Twist Bioscience worth $198M as of Q2 2026.
  • Invesco sold 243,669 Twist Bioscience shares in Q2 2026, an estimated $15.9M.
  • Twist Bioscience made up 0.02% of Invesco's portfolio in Q2 2026, its #714 holding.
  • Invesco first reported a position in Twist Bioscience in Q2 2019 and has held it in 28 quarters since.
  • Invesco's Twist Bioscience position peaked at $323M in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.